Effects of pranlukast on chemical mediators in induced sputum on provocation tests in atopic and aspirin-intolerant asthmatic patients

被引:48
|
作者
Obase, Y [1 ]
Shimoda, T [1 ]
Tomari, SY [1 ]
Mitsuta, K [1 ]
Kawano, T [1 ]
Matsuse, H [1 ]
Kohno, S [1 ]
机构
[1] Nagasaki Univ, Sch Med, Dept Internal Med 2, Nagasaki 852, Japan
关键词
allergen provocation; aspirin-intolerant asthma; aspirin oral challenge; asthma; chemical mediators; induced sputum; leukotriene receptor antagonist;
D O I
10.1378/chest.121.1.143
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background. Leukotrienes (LTs) are important in asthma, and LT modifiers modulate antigen-induced asthma. Overproduction of LT by suppression of cyclooxygenase activity is involved in patients with aspirin-intolerant asthma (AIA). Methods: House dust mite (HDM) inhalation provocation tests were performed in HDM-sensitive asthmatic inpatients without AIA (HDM group; n = 6), and aspirin oral provocation tests were performed in AIA patients (ASA group; n = 7). Tests were repeated using the same regimen after 7 days of treatment with pranlukast, an LT receptor antagonist (LTRA). The effects of pranlukast on changes in sputum LTC4-LTD4, eosinophil cationic protein (ECP), eosinophil count, urinary LTE4/creatinine, 11-dehydrothromboxane b(2) (11-dhTXB(2))/creatinine, serum LTC4-LTD4, ECP, and peripheral blood eosinophil count, during immediate asthmatic reaction (IAR) and late asthmatic reaction (LAR) in the HDM group and during LAR in the ASA group for each test, were compared in each group. Results: In the HDM group, IAR and LAR were observed. Sputum LTC4-LTD4 and urinary LTE4/creatinine increased significantly both during IAR and LAR. Sputum ECP increased during IAR and further increased during LAR. Eosinophil count in the sputum did not increase during IAR but significantly increased during LAR. Pranlukast suppressed the fall in FEV1 both during IAR and LAR (73.8% and 51.9%, respectively) and inhibited the increase in sputum eosinophil count during LAR and sputum ECP during IAR and LAR. In the ASA group, aspirin-induced IAR was associated with a fall in urinary 11-dhTXB(2)/creatinine, increased the levels of sputum LTC4-LTD4 and ECP and urinary LTE4/creatinine. Pranlukast suppressed IAR and inhibited the increase of the level of sputum ECP, but failed to change aspirin-induced LT production in the sputum and urine. The levels of sputum LTC4-LTD4 and urinary LTE4/creatinine in the stable phase in the ASA group were significantly greater than those in the HDM group. Conclusion. Our results indicated that HDM-provoked asthma is associated with overproduction of LT with an antigen-antibody reaction, while AIA is associated with overproduction of LT with a shift to the 5-lipoxygenase series of the arachidonate cascade. LTRA may be useful against both types of asthma through inhibition of LT activity and eosinophilic inflammation of the airways.
引用
收藏
页码:143 / 150
页数:8
相关论文
共 22 条
  • [1] Effects of pranlukast on aspirin-induced bronchoconstriction: differences in chemical mediators between aspirin-intolerant and tolerant asthmatic patients
    Obase, Y
    Shimoda, T
    Tomari, S
    Mitsuta, K
    Fukushima, C
    Kawano, T
    Matsuse, H
    Kohno, S
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2001, 87 (01) : 74 - 79
  • [2] EFFECTS OF CHRONIC ASPIRIN INGESTION IN ASPIRIN-INTOLERANT ASTHMATIC-PATIENTS
    NAEIJE, N
    BRACAMONTE, M
    MICHEL, O
    SERGYSELS, R
    DUCHATEAU, J
    ANNALS OF ALLERGY, 1984, 53 (03): : 262 - 264
  • [3] AEROALLERGEN INHALATION CHALLENGES IN ASPIRIN-INTOLERANT ASTHMATIC-PATIENTS
    STEVENSON, DD
    MATHISON, DA
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1975, 55 (02) : 127 - 128
  • [4] Eicosanoids in induced sputum (IS) in aspirin-tolerant (ATA) and aspirin-intolerant asthmatics (AIA)
    Kania, Aleksander
    Nizankowska, Ewa
    Bochenek, Grazyna
    Szczeklik, Andrzej
    CHEST, 2006, 130 (04) : 83S - 83S
  • [5] The interest of leucotrien-antagonists in the treatment of aspirin-intolerant asthmatic patients
    Paganin, F
    Poubeau, P
    Yvin, JL
    Arvin-Berod, C
    PRESSE MEDICALE, 2003, 32 (21): : 978 - 984
  • [6] COX-2over-expression in aspirin-intolerant patients after positive aspirin provocation
    Bajrovic, N.
    Rijavec, M.
    Silar, M.
    Kosnik, M.
    Korosec, P.
    ALLERGY, 2010, 65 : 179 - 179
  • [7] A comparative study of eicosanoid concentrations in sputum and urine in patients with aspirin-intolerant asthma
    Higashi, N
    Taniguchi, M
    Mita, H
    Osame, M
    Akiyama, K
    CLINICAL AND EXPERIMENTAL ALLERGY, 2002, 32 (10): : 1484 - 1490
  • [8] Aspirin-induced cyclooxygenase-2 overexpression in aspirin-intolerant patients
    Bajrovic, N.
    Silar, M.
    Rijavec, M.
    Kosnik, M.
    Korosec, P.
    ALLERGY, 2012, 67 : 46 - 46
  • [9] Association between a TGFβ1 promoter polymorphism and rhinosinusitis in aspirin-intolerant asthmatic patients
    Kim, Seung-Hyun
    Park, Hae-Sim
    Holloway, John W.
    Shin, Hyoung-Doo
    Park, Choon-Sik
    RESPIRATORY MEDICINE, 2007, 101 (03) : 490 - 495
  • [10] Aspirin-Induced COX-2 Overexpression in Monocytes of Aspirin-Intolerant Patients
    Morgan, Tina
    Bajrovic, Nissera
    Silar, Mira
    Kosnik, Mitja
    Korosec, Peter
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2009, 149 (04) : 378 - 384